A federal judge has declared a mistrial in the first trial to be held over whether Fosamax, Merck & Co.’s osteoporosis drug, causes painful jaw bone destruction after it became evident that jurors in the month-long trial in New York were deadlocked. Judge John F. Keenan declared a mistrial in the case brought by Plaintiff Shirley Boles. The Plaintiff, a 71-year-old Florida woman, developed severe dental and jaw-related problems several years after she began taking Fosamax in 1997.
Contact us today for a free legal consultation with an experienced attorney.
Fields marked *may be required for submission.
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.